These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4642455)

  • 1. [Clinical study on the effects of creatinol-O-phosphate in patients with heart diseases under digitalis treatment].
    Fontana A; Lusena S
    Minerva Med; 1972 Nov; 63(82):4470-81. PubMed ID: 4642455
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled clinical study of the use of creatinol-O-phosphate in subjects with deficient myocardial circulation].
    Guglielmi G; Mammarella A
    Clin Ter; 1979 Nov; 91(4):355-82. PubMed ID: 396100
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of a new digitalic drug in 50 patients: deacetyl lanatoside C].
    Arnaud JC; Rocache M
    Ann Cardiol Angeiol (Paris); 1972 Oct; 21(5):493-5. PubMed ID: 4658163
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of a new cardiotonic drug, desacetyl-lanatoside C].
    Warembourg H; Bertrand ME; Ducloux G
    Lille Med; 1972 Feb; 17():Suppl 2:169-72. PubMed ID: 5034397
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical effects of creatinol-O-phosphate in patients with heart diseases].
    Piancone RM
    Minerva Cardioangiol; 1971 Sep; 19(9):462-74. PubMed ID: 4106470
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical results of using of creatinol-O-phosphate in heart diseases. Experience in 75 cases].
    Piancone RM
    Minerva Cardioangiol; 1971 Jun; 19(6):316-28. PubMed ID: 4103851
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity of creatinol O-phosphate on persistent ventricular premature beats in ischemic heart disease. Double blind clinical trial.
    Di Maio F; Neri A; Soccorsi P; Sciacca A
    Arzneimittelforschung; 1979; 29(9a):1488-90. PubMed ID: 395959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of a new cardioactive glycoside: proscillaridin A. Case studies].
    Pagliara R
    Minerva Med; 1967 Dec; 58(96):4296-301. PubMed ID: 6081717
    [No Abstract]   [Full Text] [Related]  

  • 9. [Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides].
    Luise A
    Minerva Med; 1967 Dec; 58(96):4286-9. PubMed ID: 6083290
    [No Abstract]   [Full Text] [Related]  

  • 10. Creatinol O-phosphate therapy in patients with inadequate coronary circulation. Double-blind clinical trial.
    Barlattani M; Guglielmi G; Mammarella A
    Arzneimittelforschung; 1979; 29(9a):1483-5. PubMed ID: 395958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of the therapeutic effect of beta-methyldigoxin].
    Sorrentino F; Andreozzi GM; Carrubba A; Cottini E; Mossuti E
    Minerva Cardioangiol; 1973 Mar; 21(3):222-30. PubMed ID: 4575391
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the use of an association of ATP, cocarboxylase and beta-hydroxy-propyl-theobromine in cardiovascular therapy].
    Alberto S; Brusasco L; Colongo PG
    Minerva Cardioangiol; 1966 Sep; 14(9):557-63. PubMed ID: 5991009
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acetyldigoxin, a new cardiac glycoside].
    Burger H; Spühler O
    Schweiz Med Wochenschr; 1966 Oct; 96(41):1389-93. PubMed ID: 5972715
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of a coronary dilator and a digitalis glycoside combination].
    Bazant F; Raberger G
    Wien Klin Wochenschr; 1972 Mar; 84(11):175-81. PubMed ID: 5014174
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of the effects of creatinolo-O-phosphate in heart diseases].
    Melloni G; Camerini L; Fassini G; Saurgnani E; Marangoni R
    Minerva Med; 1968 Jun; 59(45):2600-13. PubMed ID: 5663709
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radioimmunological determination of digitalemia in maintenance therapy. Results, correlations and perspectives for application (author's transl)].
    Testoni F; Caputo V; Coppotelli L; Montemurro G; Tommaselli A
    G Ital Cardiol; 1977; 7(5):494-508. PubMed ID: 873101
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of creatinol O-phosphate in cardiac decompensation].
    Guardigli R
    Minerva Cardioangiol; 1971 May; 19(5):265-71. PubMed ID: 5092264
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of therapy of heart diseases in old age].
    Lang E; Wittmann G
    Z Gerontol; 1991; 24(4):171-8. PubMed ID: 1950082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of patients with coronary insufficiency with creatinol-o-phosphate].
    Natale L
    Minerva Med; 1968 Apr; 59(29):1696-708. PubMed ID: 5648218
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the use ofa ajmaline as an adjuvant in the therapy and prevention of arrhythmias during digitalic treatment].
    Marangoni R; Brera V; Ferrari A
    Minerva Med; 1968 Feb; 59(14):749-59. PubMed ID: 5643083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.